About this trial
The ENRICH study is aimed to Enpower patieNts with metabolic syndrome (Mets) to increase their Risk perception and to acquire health Information necessary for Capability building and promotion of Health information literacy, as well as health outcomes. The purpose of this clinical trial is to evaluate the efficacy of this health information literacy promotion intervention based on Health Empowerment Theory in individuals with metabolic syndrome. The study aims to answer the following questions:
Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)?
Participants will:
Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in terms of their level of health information literacy and health outcomes.
Eligibility criteria
Qualifiers
Age ≥ 18 years old and ≤ 75 years old;;
Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women)
Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment
Blood pressure ≥ 130/85 mmHg and/or hypertension treatment
Disqualifiers
Patients with severe liver and kidney dysfunction, cancer, severe cardiovascular and cerebrovascular diseases, gout, etc., which seriously endanger life, have abnormal nutritional status and require special diet;
Pregnant patients;
Patients with a history of mental illness and cognitive impairment;
Those currently participating in other research projects.
Trial design
Treatments tested in this trial
- ENRICH Group
- Routine Care Group
Treatment groups
Sponsors and collaborators
Meihua Ji
Lead sponsor
Capital Medical University
Sponsor institution
The Luhe Teaching Hospital of the Capital Medical University
Collaborator